Close
  Indian J Med Microbiol
 

Figure 2: The effect of antiviral treatment on t(14;18) in patients with chronic HCV infection. Detection of t(14;18) by MBR bcl-2/JH nested PCR in PBMCs from patients with chronic HCV infection before and after antiviral treatment. Lane 1: molecular weight marker; lanes 2 and 3: presence of t(14;18) in both pre-treatment and post-treatment samples; lanes 4 and 5: absence of t(14;18) in both pre-treatment and post-treatment samples; lanes 6 and 7: loss of pretreatment t(14;18) in the post-treatment sample; lanes 8 and 9: presence of t(14;18)i in both pre-treatment and post-treatment samples; lane 10: positive control cell line (DOHH2); lane 11: negative control. HCV, hepatitis C virus; PBMCs, peripheral blood mononuclear cells.

Figure 2: The effect of antiviral treatment on <i>t(14;18)</i> in patients with chronic HCV infection. Detection of <i>t(14;18)</i> by MBR bcl-2/JH nested PCR in PBMCs from patients with chronic HCV infection before and after antiviral treatment. Lane 1: molecular weight marker; lanes 2 and 3: presence of <i>t(14;18)</i> in both pre-treatment and post-treatment samples; lanes 4 and 5: absence of <i>t(14;18)</i> in both pre-treatment and post-treatment samples; lanes 6 and 7: loss of pretreatment <i>t(14;18)</i> in the post-treatment sample; lanes 8 and 9: presence of <i>t(14;18)</i>i in both pre-treatment and post-treatment samples; lane 10: positive control cell line (DOHH2); lane 11: negative control. HCV, hepatitis C virus; PBMCs, peripheral blood mononuclear cells.